Live feed19:51:04·603dINSIDERFilingvia QuantisnowCFO and Chief Business Officer Gengos Andrew was granted 15,000 shares and sold $720 worth of shares (1,272 units at $0.57), increasing direct ownership by 16% to 97,532 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ATHA· Athira Pharma Inc.Health CareOriginal source